Chung‐Yu Chang

2.1k total citations
58 papers, 1.6k citations indexed

About

Chung‐Yu Chang is a scholar working on Molecular Medicine, Molecular Biology and Endocrinology. According to data from OpenAlex, Chung‐Yu Chang has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 13 papers in Molecular Biology and 12 papers in Endocrinology. Recurrent topics in Chung‐Yu Chang's work include Antibiotic Resistance in Bacteria (15 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Bacterial Genetics and Biotechnology (7 papers). Chung‐Yu Chang is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Bacterial Genetics and Biotechnology (7 papers). Chung‐Yu Chang collaborates with scholars based in Taiwan, United States and Austria. Chung‐Yu Chang's co-authors include Ry Young, Hagan Bayley, Udo Bläsi, Tsong-Ming Lee, J.-T. Lin, Lin‐Li Chang, Po‐Liang Lu, Barbara Walker, Jyh‐Ming Liou and Ming‐Shiang Wu and has published in prestigious journals such as Journal of the American Chemical Society, The EMBO Journal and Blood.

In The Last Decade

Chung‐Yu Chang

57 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chung‐Yu Chang Taiwan 26 534 378 329 286 277 58 1.6k
Yoshikazu Furuta Japan 20 880 1.6× 233 0.6× 326 1.0× 145 0.5× 98 0.4× 54 1.5k
Daniel Vinella France 21 866 1.6× 251 0.7× 94 0.3× 170 0.6× 145 0.5× 29 1.5k
Jim Manos Australia 21 764 1.4× 166 0.4× 75 0.2× 377 1.3× 197 0.7× 42 1.4k
Valérie Michel France 25 709 1.3× 178 0.5× 452 1.4× 35 0.1× 136 0.5× 60 1.7k
Benoît Marteyn France 23 1.0k 1.9× 186 0.5× 148 0.4× 134 0.5× 541 2.0× 39 2.3k
I.B. Holland France 19 824 1.5× 228 0.6× 124 0.4× 289 1.0× 281 1.0× 30 1.9k
Neal D. Hammer United States 28 1.6k 3.0× 161 0.4× 266 0.8× 215 0.8× 218 0.8× 53 2.8k
Maurice P. Gallagher United Kingdom 17 967 1.8× 129 0.3× 142 0.4× 141 0.5× 78 0.3× 28 2.0k
Vinai C. Thomas United States 26 1.3k 2.4× 180 0.5× 118 0.4× 177 0.6× 179 0.6× 53 2.2k
Anne Walburger France 17 679 1.3× 154 0.4× 59 0.2× 95 0.3× 140 0.5× 20 1.3k

Countries citing papers authored by Chung‐Yu Chang

Since Specialization
Citations

This map shows the geographic impact of Chung‐Yu Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Yu Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Yu Chang more than expected).

Fields of papers citing papers by Chung‐Yu Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Yu Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Yu Chang. The network helps show where Chung‐Yu Chang may publish in the future.

Co-authorship network of co-authors of Chung‐Yu Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Yu Chang. A scholar is included among the top collaborators of Chung‐Yu Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Yu Chang. Chung‐Yu Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peters, D., Chung‐Yu Chang, Anson Snow, et al.. (2024). Azacitidine and Venetoclax with or without Donor Lymphocyte Infusion in Relapsed AML Post Allo-HSCT: A Single-Institution Retrospective Study. Blood. 144(Supplement 1). 1481–1481.
2.
3.
Hsin, I‐Fang, et al.. (2020). The indocyanine green retention test as a noninvasive marker for esophageal varices in patients with hepatocellular carcinoma. Journal of the Chinese Medical Association. 83(8). 737–742. 2 indexed citations
4.
Chang, Chung‐Yu, Ping‐Hsien Chen, & Ming‐Chih Hou. (2017). Esophageal Mammary Analogue Secretory Carcinoma. Clinical Gastroenterology and Hepatology. 16(2). e11–e12. 7 indexed citations
5.
Chang, Chung‐Yu, Lin‐Li Chang, Ling Ma, et al.. (2016). Characterization of Extended-Spectrum β-Lactamase-Carrying Plasmids in Clinical Isolates of Klebsiella pneumoniae from Taiwan. Microbial Drug Resistance. 23(1). 98–106. 6 indexed citations
6.
Liou, Jyh‐Ming, et al.. (2015). Modified Sequential Therapy Containing Levofloxacin Versus Levofloxacin Triple Therapy in the Second Line Treatment of Helicobacter pylori: A Randomized Trial. Clinical Gastroenterology and Hepatology. 13(7). 1384–1384. 1 indexed citations
7.
Tseng, Sung‐Pin, Wan-Chi Tsai, Junwei Huang, et al.. (2014). The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity. PLoS ONE. 9(8). e104986–e104986. 45 indexed citations
8.
Liou, Jyh‐Ming, Chieh‐Chang Chen, Chung‐Yu Chang, et al.. (2012). Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial. Journal of Antimicrobial Chemotherapy. 68(2). 450–456. 68 indexed citations
9.
Liou, Jyh‐Ming, Chieh‐Chang Chen, Mei‐Jyh Chen, et al.. (2011). Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial. Journal of Antimicrobial Chemotherapy. 66(8). 1847–1852. 41 indexed citations
10.
11.
Cheng, Ta‐Chih, et al.. (2009). Visible light activated bactericidal effect of TiO2/Fe3O4 magnetic particles on fish pathogens. Surface and Coatings Technology. 204(6-7). 1141–1144. 38 indexed citations
12.
Chang, Chung‐Yu, et al.. (2009). Gp15 and gp16 cooperate in translocating bacteriophage T7 DNA into the infected cell. Virology. 398(2). 176–186. 58 indexed citations
13.
Cheng, Ta‐Chih, et al.. (2008). Comparison of photocatalytic activities of various dye-modified TiO2 thin films under visible light. Surface and Coatings Technology. 203(5-7). 922–924. 25 indexed citations
14.
Chang, Chung‐Yu. (2004). Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. Journal of Antimicrobial Chemotherapy. 53(3). 553–553. 3 indexed citations
15.
16.
Lee, Tsong-Ming, et al.. (2003). One predominant type of genetically closely related Shigella sonnei prevalent in four sequential outbreaks in school children. Diagnostic Microbiology and Infectious Disease. 45(3). 173–181. 17 indexed citations
17.
Chang, Chung‐Yu, et al.. (2000). Characterisation of drug resistance gene cassettes associated with class 1 integrons in clinical isolates of Escherichia coli from Taiwan, ROC. Journal of Medical Microbiology. 49(12). 1097–1102. 75 indexed citations
18.
19.
Barenboim, Maxim, et al.. (1999). Characterization of the dual start motif of a class II holin gene. Molecular Microbiology. 32(4). 715–727. 50 indexed citations
20.
Chang, Chung‐Yu, et al.. (1993). Synthesis of two bacteriophage λ, S proteins in an in vivo system. Gene. 133(1). 9–16. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshikazu Furuta Breakdown of academic impact, for papers by Daniel Vinella Breakdown of academic impact, for papers by Jim Manos Breakdown of academic impact, for papers by Valérie Michel Breakdown of academic impact, for papers by Benoît Marteyn Breakdown of academic impact, for papers by I.B. Holland Breakdown of academic impact, for papers by Neal D. Hammer Breakdown of academic impact, for papers by Maurice P. Gallagher Breakdown of academic impact, for papers by Vinai C. Thomas Breakdown of academic impact, for papers by Anne Walburger
Rankless by CCL
2026